Archive for erbitux
You are browsing the archives of erbitux.
Bristol-Myers Offers $4.5M For ImClone Systems
Offer Represents Approximately 30% Premium to the Closing Price of ImClone’s Stock on July 30, Approximately 40% Premium to the Average Share Price of ImClone Common Stock During the Most Recent One-Month Period and Premium in Excess of 40% for the Average Share Prices of ImClone Stock During the Most Recent Three-Month and 12-Month Periods Combination Is Natural Development in Companies’ Successful, Seven-Year-Long Relationship around ERBITUX(R)
Popularity: 1% [?]
